Literature DB >> 11672907

DNA vaccination with asparaginyl endopeptidase (Sm32) from the parasite Schistosoma mansoni: anti-fecundity effect induced in mice.

K Chlichlia1, M Bahgat, A Ruppel, V Schirrmacher.   

Abstract

DNA-based vaccine technology was used to induce an immune response in mice against a schistosome cysteine proteinase, asparaginyl endopeptidase (Sm32). The cDNA coding for Sm32 was cloned in a mammalian expression vector under control of the CMV promoter/enhancer and expressed for the first time in transfected mammalian cells as well as in mice immunized with the Sm32-encoding DNA construct. These mice developed antibodies which recognized the native protein not only in homogenates of Schistosoma mansoni worms but also in the gut on cryostat sections of the parasites. This DNA vaccine led to an anti-fecundity effect: female worms of a challenge infection produced 37% less eggs than those growing in naïve mice. The results suggest that Sm32 may be a candidate antigen for the generation of an anti-pathology vaccine against schistosomes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11672907     DOI: 10.1016/s0264-410x(01)00345-0

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Vector-based RNA interference of cathepsin B1 in Schistosoma mansoni.

Authors:  Elissaveta B Tchoubrieva; Poh C Ong; Robert N Pike; Paul J Brindley; Bernd H Kalinna
Journal:  Cell Mol Life Sci       Date:  2010-03-26       Impact factor: 9.261

2.  Nucleic acid vaccination with Schistosoma mansoni antioxidant enzyme cytosolic superoxide dismutase and the structural protein filamin confers protection against the adult worm stage.

Authors:  Rosemary M Cook; Claudia Carvalho-Queiroz; Gregory Wilding; Philip T LoVerde
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

3.  Towards a metalloprotease-DNA vaccine against piscine cryptobiosis caused by Cryptobia salmositica.

Authors:  Chung-Wei Tan; Palmy Jesudhasan; Patrick T K Woo
Journal:  Parasitol Res       Date:  2007-10-12       Impact factor: 2.289

Review 4.  Interaction Between the Neglected Tropical Disease Human Schistosomiasis and HCV Infection in Egypt: a Puzzling Relationship.

Authors:  Mahmoud M Bahgat
Journal:  J Clin Transl Hepatol       Date:  2014-06-15

Review 5.  Kicking in the Guts: Schistosoma mansoni Digestive Tract Proteins are Potential Candidates for Vaccine Development.

Authors:  Barbara Castro-Pimentel Figueiredo; Natasha Delaqua Ricci; Natan Raimundo Gonçalves de Assis; Suellen Batistoni de Morais; Cristina Toscano Fonseca; Sergio Costa Oliveira
Journal:  Front Immunol       Date:  2015-01-28       Impact factor: 7.561

Review 6.  Schistosomiasis vaccines: where do we stand?

Authors:  Biniam Mathewos Tebeje; Marina Harvie; Hong You; Alex Loukas; Donald P McManus
Journal:  Parasit Vectors       Date:  2016-09-30       Impact factor: 3.876

7.  SmCL3, a gastrodermal cysteine protease of the human blood fluke Schistosoma mansoni.

Authors:  Jan Dvorák; Susan T Mashiyama; Mohammed Sajid; Simon Braschi; Melaine Delcroix; Eric L Schneider; Wilson H McKerrow; Mahmoud Bahgat; Elizabeth Hansell; Patricia C Babbitt; Charles S Craik; James H McKerrow; Conor R Caffrey
Journal:  PLoS Negl Trop Dis       Date:  2009-06-02

8.  A Proteomic Analysis of the Body Wall, Digestive Tract, and Reproductive Tract of Brugia malayi.

Authors:  C Paul Morris; Sasisekhar Bennuru; Laura E Kropp; Jesse A Zweben; Zhaojing Meng; Rebekah T Taylor; King Chan; Timothy D Veenstra; Thomas B Nutman; Edward Mitre
Journal:  PLoS Negl Trop Dis       Date:  2015-09-14

Review 9.  Current status and future prospects of protein vaccine candidates against Schistosoma mansoni infection.

Authors:  Tahir Eyayu; Ayalew Jejaw Zeleke; Ligabaw Worku
Journal:  Parasite Epidemiol Control       Date:  2020-08-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.